Literature DB >> 10872515

Mycotoxins of fungal strains from stored herbal plants and mycotoxin contents of Nigerian crude herbal drugs.

M O Efuntoye1.   

Abstract

The ability of fungi isolated from stored herbal drug plants to produce mycotoxins in semisynthetic media was studied. The results obtained show that aflatoxins and ochratoxin A, were produced by Aspergillus flavus, A. parasiticus and A. ochraceus isolates. The time-production courses of aflatoxins B1, B2, 1 and ochratoxin A in crude herbal drug preparations show that more of these toxins were produced with increase in time of storage of the drugs. The results indicate that the potential exists for the toxigenic strains to elaborate mycotoxins in a large quantity in herbal drug substrates than in semisynthetic media.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10872515     DOI: 10.1023/a:1007007418581

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  10 in total

1.  Collaborative study of a method for chemical confirmation of the identity of aflatoxin.

Authors:  M E Stack; A E Pohland
Journal:  J Assoc Off Anal Chem       Date:  1975-01

2.  Growth and aflatoxin production by Aspergillus parasiticus from various carbon sources.

Authors:  N D Davis; U L Diener
Journal:  Appl Microbiol       Date:  1968-01

3.  Effect of roasting on ochratoxin A level in green coffee beans inoculated with Aspergillus ochraceus.

Authors:  H Tsubouchi; K Yamamoto; K Hisada; Y Sakabe; S Udagawa
Journal:  Mycopathologia       Date:  1987-02       Impact factor: 2.574

4.  Production of aflatoxins B1 and G1 by Aspergillus flavus in a semisynthetic medium.

Authors:  N D Davis; U L Diener; D W Eldridge
Journal:  Appl Microbiol       Date:  1966-05

5.  Aflatoxin production by isolates of Aspergillus flavus.

Authors:  U L Diener; N D Davis
Journal:  Phytopathology       Date:  1966-12       Impact factor: 4.025

6.  The relationship of Aspergillus flavus and Aspergillus parasiticus with reference to production of aflatoxins and cyclopiazonic acid.

Authors:  J W Dorner; R J Cole; U L Diener
Journal:  Mycopathologia       Date:  1984-08-30       Impact factor: 2.574

7.  Temperature and aflatoxin production by Aspergillus flavus and A. parasiticus strains from Nigerian groundnuts.

Authors:  V W Ogundero
Journal:  J Basic Microbiol       Date:  1987       Impact factor: 2.281

8.  Aflatoxin contamination of some common drug plants.

Authors:  A K Roy; K K Sinha; H K Chourasia
Journal:  Appl Environ Microbiol       Date:  1988-03       Impact factor: 4.792

9.  Production of ochratoxin A by Aspergillus ochraceus in a semisynthetic medium.

Authors:  N D Davis; J W Searcy; U L Diener
Journal:  Appl Microbiol       Date:  1969-05
  10 in total
  6 in total

1.  Contamination of aflatoxins in herbal medicinal products in Thailand.

Authors:  Wongwiwat Tassaneeyakul; Ebrahim Razzazi-Fazeli; Supatra Porasuphatana; Josef Bohm
Journal:  Mycopathologia       Date:  2004-08       Impact factor: 2.574

2.  Mixed herbs drugs: inhibitory effect on growth of the endogenous mycoflora and aflatoxin production.

Authors:  Mohd Fuat Abd Razak; K E Aidoo; A G G Candlish
Journal:  Mycopathologia       Date:  2008-11-08       Impact factor: 2.574

3.  Herbal medicine use among urban residents in Lagos, Nigeria.

Authors:  Ibrahim Adekunle Oreagba; Kazeem Adeola Oshikoya; Mercy Amachree
Journal:  BMC Complement Altern Med       Date:  2011-11-25       Impact factor: 3.659

4.  Development of standard operating procedure and standardization of Habb-e-Banafsha Qawi-A Unani polyherbal formulation.

Authors:  Athar Ali; Sabiha Sumbul; Malik Mobeen Ahmad; Sayeed Ahmad; Hifzul Kabir; M Z Abdin
Journal:  J Pharm Bioallied Sci       Date:  2015 Oct-Dec

5.  MYCOLOGICAL ANALYSIS AND AFLATOXIN B1 CONTAMINANT ESTIMATION OF HERBAL DRUG RAW MATERIALS.

Authors:  Puttaswamy Rajeshwari; KoteshwarAnandrao Raveesha
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-08-12

6.  Use of complementary and alternative medicines for children with chronic health conditions in Lagos, Nigeria.

Authors:  Kazeem A Oshikoya; Idowu O Senbanjo; Olisamedua F Njokanma; Ayo Soipe
Journal:  BMC Complement Altern Med       Date:  2008-12-29       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.